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appearance were present. The atypical cells were focally arranged
in short single-file lines. No tumour diathesis or mitotic activity was

In 2014, the use of the Cobas HPV test for primary cervical cancer

identified (Figure 1A,B). Upon review of the patient's medical record,

screening for women who are 25 years and older without the need

a remote history of breast cancer was discovered. A cell block was

for a concomitant Pap test was approved by the US Food and Drug

prepared by Cellient Automated Cell Block System (Hologic, Inc.),

Administration (FDA). Primary HPV testing will be incorporated

and immunohistochemistry (IHC) was performed to further clarify

into the updated American Society for Colposcopy and Cervical

the nature of the abnormal cells. The cells were positive for GATA3

Pathology (ASCCP) guidelines in 2020 as a screening option for pa-

(Figure 1C) and negative for PAX8 and oestrogen receptor (ER). The

tients 25 years of age and older. However, because a high-risk HPV

overall cytomorphologic and immunophenotypic findings were suspi-

infection is not associated with an endometrial or metastatic car-

cious for adenocarcinoma and suggestive of breast origin. Concurrent

cinoma, HPV DNA testing alone would not detect these cancers.

high-risk HPV testing was negative. The Pap test was signed out

We describe here a 64-year-old woman who had a remote history

as “Atypical glandular cells, favour neoplastic, suggestive of breast

of breast cancer and presented for a routine Pap test. The diagnosis

origin.”

of “atypical glandular cells, favour neoplastic, suggestive of breast

The patient's previous breast cancer (diagnosed in 2002) was

origin” was rendered cytologically and supported by the results of

reviewed and showed infiltrating carcinoma with both ductal and

cervical and endometrial biopsies. We present detailed cytological

lobular features (Figure 2A). The patient had undergone a partial

and clinical findings of this very rare occurrence, and review liter-

mastectomy, followed by adjuvant chemotherapy, whole breast ra-

ature of reported metastatic breast cancer cases detected on Pap

diotherapy, and hormonal therapy; she completed all treatment in

test. Our case underscores the continued relevance and importance

2013.

of the Pap test in certain patient populations for whom conventional

Following the abnormal cytology, the patient returned to the

cervical cytology may have added value compared to primary HPV

clinic for colposcopy, and cervical biopsies were obtained. The

screening.

biopsies showed a microscopic focus of adenocarcinoma consistent with metastatic breast cancer (Figure 2B); the malignant cells
were positive for GATA3 (Figure 2C) and negative for p16. The
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patient also had an endometrial biopsy, which showed metastatic
breast cancer with small, dyshesive tumour cells present in the

A 64-year-old postmenopausal woman with a past medical history of

endometrial stroma (Figure 3A). The tumour cells were positive

fibroids, gastroesophageal reflux disease, and obesity presented for

for GATA3 (Figure 3B), ER, and progesterone receptor (PR), and

her annual gynaecological exam. Her pelvic exam was normal, and

negative for HER2 and E-cadherin (Figure 3C) by IHC. However,

the patient was asymptomatic. However, the ThinPrep Papanicolaou

her pelvic ultrasound showed a normal-sized uterus with no focal

(Pap) test (Hologic, Inc.) showed multiple small groups of cells with

abnormalities. Additionally, the patient's most recent mammo-

scant cytoplasm, irregular nuclear contours, and inconspicuous

gram, completed one month before the abnormal Pap test, was

small nucleoli. Rare cytoplasmic vacuoles imparting a signet-ring cell

normal.
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(A)

(A)

(B)

(B)

(c)

(C)

GATA-3
F I G U R E 1 Cytological and immunocytochemical features of the
atypical glandular cells on the Pap test. (A) The ThinPrep Pap test
showed small groups of cells with scant cytoplasm, irregular nuclear
contours, and inconspicuous small nucleoli. (B) The atypical cells
were focally arranged in short single-file lines, and (C) were positive
for GATA3 by immunohistochemistry (A, ThinPrep Papanicolaou
stain, 400×; B, Cell block H&E, 400×; C, 400×)

GATA-3
F I G U R E 2 Previous mastectomy and follow-up cervical biopsy.
(A) The patient's previous breast cancer (17 years prior) was
reviewed, and showed infiltrating carcinoma with both ductal
and lobular features (H&E, 100×). (B) Subsequent cervical biopsy
showed metastatic breast cancer with small, dyshesive tumour cells
present in the ectocervical stroma (H&E, 40×). (C) The tumour cells
were positive for GATA3 by immunohistochemistry (100×)
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(A)

3

Subsequent imaging revealed multiple osseous lesions and the
patient was treated for metastatic ER/PR positive breast cancer. The
patient tolerated the treatment well, and follow-up imaging showed
a complete response, with no residual tumour identified.
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Screening for cervical cancers with the Pap test has been very effective in reducing the incidence of cervical cancer and mortality in the
United States, with an observed decline by more than 70%
since the 1950s.1 However, the Pap test has a lower sensitivity
for detecting glandular lesions than for squamous lesions and “atypical glandular cells” (ACG) may be a consequence of benign as well
as neoplastic conditions of the cervix, upper endocervical canal or
higher in the gynaecological tract. Some cases of ovarian, vaginal,

(B)

and even colon or breast cancer have been reported after an AGC
Pap test interpretation, 2,3,4 but the diagnosis of metastatic extragenital malignancy on a cervical smear is rare.5 In a study of 3007
women with AGC, 433 patients (14.4%) had precancerous or malignant lesions on histologic follow-up and 14 cases (3% of these) were
metastatic carcinoma.6 In another study of 143 glandular epithelial
abnormalities, five cases of metastatic lesions to the cervix were
identified (3.5%), including three cases of colorectal adenocarcinoma and two cases of serous papillary carcinoma. 2 The majority of
patients who were found to have metastatic extragenital malignancy
on a cervical smear had undergone cervical smear because of vaginal bleeding, or rarely an incidental finding noted after a routine
Pap test. Akhtar et al reported a case of lobular carcinoma of the

GATA-3
(C)

breast in a 62-year-old postmenopausal female following an abnormal screening mammogram. Similar to our case, a routine Pap test
necessitated further workup, revealing synchronous endometrial
and cervical metastases.5 A literature search of patients with cervical (with or without uterine) metastases of breast cancer revealed on
Pap test (without or without co-current cervical biopsy) identified a
total of twenty-four previously published cases; nine were ductal,
and fourteen were lobular (one was not specified).5-23 Cases with
isolated cervical metastases and cases with disseminated metastatic
disease with cervical involvement were reported. The majority of
cases had no gross evidence of malignancy on examination. Our case
is somewhat unique, as the primary tumour metastasis in the axillary
lymph nodes was the ductal component, but the late metastasis was
the lobular component seventeen years later (Figure 4).

E-cadherin
F I G U R E 3 Follow-up endometrial biopsy. (A) Subsequent
endometrial biopsy showed metastatic breast cancer with
small, dyshesive tumour cells present in the endometrial stroma
(H&E, 100×). (B) The tumour cells were positive for GATA3 by
immunohistochemistry (100×). (C) The tumour cells were negative
for E-cadherin by immunohistochemistry (100×)

The discrepancy in ER expression between the cytology and
subsequent histology was presumably due to the cell block preparation method that was used in this case. As the cells in the cervical
fluid specimen were already fixed in PreservCyt® for ThinPrep, we
prepared a cell block using Cellient™ Automated Cell Block System.
Correlation with the histology findings in this case demonstrated
that ER was expressed in 99% of cells in the endometrial biopsy, suggesting a negative ER status result on cell block material is a false
negative. Cellient is a proprietary automated system which produces
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these cancers. Our case illustrates that the Pap test can detect met-

(A)

astatic cancer from an extrauterine source, and clinicians should be
aware of some of the limitations of the potential use of the HPV
test as the primary screening tool in comparison with the Pap test
alone, or co-testing with both Pap and HPV testing. The new ASCCP
guidelines are expected to be published in the summer of 2020.
The new guidelines will incorporate the patient's current and past
results to create an individualised assessment of a patient's risk of
progressing to pre-cancer or cancer. In addition, primary HPV testing will be incorporated into the updated guidelines as a screening
option for patients 25 years of age and older. Healthcare providers
should continue to be vigilant in following up on patients with any
glandular abnormalities on the Pap test, especially those who are
symptomatic (abnormal bleeding) or have a history of cancer. This
case underscores the continued relevance and importance of the
Pap test in certain patient populations for whom conventional cy-

(B)

tology may have added value compared to primary HPV screening.
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E-cadherin
F I G U R E 4 (A) Metastatic carcinoma in the axillary lymph
node resected 17 years prior was the ductal component (H&E,
100×). (B) The nodal metastases were positive for E-cadherin by
immunohistochemistry (100×)
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